Literature DB >> 32077600

Hepatitis C elimination - Macro-elimination.

Martin Kåberg1,2, Ola Weiland1.   

Abstract

In 2016 the WHO set a goal to obtain an 80% reduction in new chronic HCV cases, requiring a level of diagnosis of 90%, treatment coverage of 80% and resulting in a 65% reduction in HCV-related deaths by 2030. This goal is easier to reach in specific populations such as people who inject drugs (PWID), men who have sex with men (MSM) or blood-transfusion recipients before screening for HCV became mandatory and in high-income regions. It is much more difficult to achieve macro-elimination throughout the population especially in low-income areas with underdeveloped infrastructures, a high prevalence of HCV and limited economic resources. To achieve the WHO goals by 2030, awareness of HCV must increase and the cascade of care must be improved and implemented. Diagnostic procedures and treatment should be affordable and universally available. At the end of 2017 fewer than 15 countries were on track to reach these goals by 2030.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HCV; HCV care cascade; HCV screening; macro-elimination

Mesh:

Year:  2020        PMID: 32077600     DOI: 10.1111/liv.14352

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  2 in total

Review 1.  Viral hepatitis and pregnancy.

Authors:  Norah A Terrault; Miriam T Levy; Ka Wang Cheung; Gonzague Jourdain
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-12       Impact factor: 46.802

2.  Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.

Authors:  Anita Y M Howe; Chaturaka Rodrigo; Evan B Cunningham; Mark W Douglas; Julia Dietz; Jason Grebely; Stephanie Popping; Javier Alejandro Sfalcin; Milosz Parczewski; Christoph Sarrazin; Adolfo de Salazar; Ana Fuentes; Murat Sayan; Josep Quer; Midori Kjellin; Hege Kileng; Orna Mor; Johan Lennerstrand; Slim Fourati; Velia Chiara Di Maio; Vladimir Chulanov; Jean-Michel Pawlotsky; P Richard Harrigan; Francesca Ceccherini-Silberstein; Federico Garcia
Journal:  JHEP Rep       Date:  2022-02-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.